All news

Boom time for CROs?

Boom time for CROs?

The amount of pharmaceutical R&D funding headed out-of-house to
research suppliers engaged in drug development work will grow
almost 15 per cent annually for the next five years, nearly double
the anticipated increase in overall...

Sad demise of PPL

Sad demise of PPL

Scotland's PPL Therapeutics, once one of the brightest stars in the
UK biotechnology universe, came to desultory end this week when the
company auctioned off most of its remaining assets for just
£169,000 (€242,000).

First draft of chimp genome

First draft of chimp genome

The first draft sequence of the genome of the chimpanzee has been
completed, providing a tantalising first glimpse of the genetic
differences that separates man from one of its closest cousins in
the animal kingdom.

Follow us

Products

View more

Webinars